Cheng Han Ng

Kurume University — Japan

Medicine · Health Sciences

50h-index9.6kcitations284works12.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(156), Liver Disease and Transplantation(59), Diet, Metabolism, and Disease(41), Alcohol Consumption and Health Effects(37), Hepatocellular Carcinoma Treatment and Prognosis(31)

Publications284 total

Defining weight trajectory after liver transplantation using generative artificial intelligence
Liver Transplantation·2025· 1 cited
Rising burden of steatotic liver disease in women of childbearing age and projections to 2035
JHEP Reports·2025Open Access
Meta‐Analysis: Utilisation of Hepatocellular Carcinoma Surveillance
Alimentary Pharmacology & Therapeutics·2025· 1 cited
Incidence of Hepatocellular Carcinoma in Metabolic Dysfunction-associated Steatotic Liver Disease: A Reconstructed Individual Patient Data Meta-analysis
Clinical Gastroenterology and Hepatology·2025· 1 cited
Quantification of liver steatosis of metabolic dysfunction-associated steatotic liver disease based on body composition analysis
Scientific Reports·2025· 1 citedOpen Access
Quantification of liver steatosis of metabolic dysfunction-associated steatotic liver disease based on body composition analysis
2025Open Access
Hepatocellular Carcinoma Surveillance and Survival in a Contemporary Asia-Pacific Cohort
JAMA Network Open·2025· 5 citedOpen Access
The Rising Global Burden of MASLD and Other Metabolic Diseases (2000–2021)
United European Gastroenterology Journal·2025· 17 citedOpen Access
Meta‐Analysis: Effects of Steatotic Liver Disease‐Associated Genetic Risk Alleles on Longitudinal Outcomes
Alimentary Pharmacology & Therapeutics·2025· 5 citedOpen Access
SAT-452 GLP1 agonist and metabolic dysfunction-associated steatohepatitis (MASH): systematic review and meta-analysis
Journal of Hepatology·2025
WED-131 Low FIB-4 in multinational hepatocellular carcinoma cohort
Journal of Hepatology·2025
WED-142 Impact of hepatocellular carcinoma surveillance on survival in a contemporary international cohort
Journal of Hepatology·2025
Alcohol‐Attributable Cancer: Update From the Global Burden of Disease 2021 Study
Alimentary Pharmacology & Therapeutics·2025· 6 cited
The Global Burden of Cirrhosis and Other Chronic Liver Diseases in 2021
Liver International·2025· 31 citedOpen Access
Artificial Intelligence and Machine Learning Predicting Transarterial Chemoembolization Outcomes: A Systematic Review
Digestive Diseases and Sciences·2024· 8 cited
Neighborhood Social Determinants of Health Are Associated With Metabolic Dysfunction-associated Steatotic Liver Disease Outcomes
Clinical Gastroenterology and Hepatology·2024· 5 cited
Liver cancer in 2021: Global Burden of Disease study
Journal of Hepatology·2024· 128 cited
Prevalence of Low FIB‐4 in MASLD‐Related Hepatocellular Carcinoma: A Multicentre Study
Alimentary Pharmacology & Therapeutics·2024· 15 citedOpen Access
Prevalence of Chronic Liver Disease in Cholangiocarcinoma: A Meta-Analysis
Clinical Gastroenterology and Hepatology·2024· 1 cited
Prevalence and longitudinal effects on mortality associated with spectrum of alcohol intake in steatotic liver disease: a United States population study
HepatoBiliary Surgery and Nutrition·2024· 2 citedOpen Access
page 1 of 15Next →

Frequent Co-authors

Mark Muthiah(36), Darren Jun Hao Tan(27), Wen Hui Lim(26), Daniel Q. Huang(24), Nicholas Chew(19), Yip Han Chin(18), Nicholas Syn(15), Mohammad Shadab Siddiqui(13), Mark Y. Chan(13), Arun J. Sanyal(13), Kai En Chan(13), Jieling Xiao(12), Chin Meng Khoo(12), Mazen Noureddin(12), Jie Ning Yong(12), Phoebe Wen Lin Tay(10), Rohit Loomba(10), Ansel Shao Pin Tang(9), Jingxuan Quek(8), Jiong‐Wei Wang(8)